News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current RNUGF market cap is 62.89k. The company's latest EPS is GBP -0.0946 and P/E is -0.32.
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 2.72M | 6.17M | 335k | 403k | 530k |
| Operating Income | -18.3M | -14.41M | -12.91M | -11.23M | -7.12M |
| Net Income | -14.35M | -11.41M | -11.35M | -9.69M | -5.41M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 31.51M | 20.38M | 25.35M | 17.32M | 9.65M |
| Total Liabilities | 8.27M | 7.15M | 6.45M | 7.44M | 4.59M |
| Total Equity | 23.24M | 13.22M | 18.91M | 9.89M | 5.06M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -11.95M | -14.3M | -6.05M | -7.41M | -7.48M |
| Investing | 103k | 181k | 2k | 2.22M | 3.91M |
| Financing | 4.37M | 6.32M | 8.61M | -134k | -147k |
| Market Cap | 62.89k |
| Price to Earnings Ratio | -0.32 |
| Price to Sales Ratio | 3.28 |
| Price to Cash Ratio | 0.28 |
| Price to Book Ratio | 0.34 |
| Dividend Yield | - |
| Shares Outstanding | 57.17M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 2.5k |
| 52 Week Change | -98.41% |
| 52 Week High | 0.092 |
| 52 Week Low | 0.0011 |
| Spread (Intraday) | 386k (100%) |
| Company Name | Reneuron Group Plc (PK) |
| Address |
pencoed business park london CF35 5HY |
| Website | https://www.reneuron.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
